Researchers identify genetic changes responsible for rare childhood immune disorders
Affecting the immune system, various forms of SCID are estimated to affect one in 75,000 to 100,000 newborns
Read More
Tag: NUDCD3
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
- Zenas reports strong phase 3 results for obexelimab in IgG4-related disease
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
